Release Date: 30/09/09 14:02 Summary: Annual Financial Statements - 30 June 2009 Price Sensitive: No Download Document 624.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%